The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Subclinical Atrial Fibrillation and the Risk of Stroke
Open accessAbstract
BACKGROUND: One quarter of strokes are of unknown cause, and subclinical atrial fibrillation may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial rate, which correlate with electrocardiographically documented atrial fibrillation. We evaluated whether subclinical episodes of rapid atrial rate detected by implanted devices were associated with an increased risk of ischemic stroke in patients who did not have other evidence of atrial fibrillation. METHODS: We enrolled 2580 patients, 65 years of age or older, with hypertension and no history of atrial fibrillation, in whom a pacemaker or defibrillator had recently been implanted. We monitored the patients for 3 months to detect subclinical atrial tachyarrhythmias (episodes of atrial rate >190 beats per minute for more than 6 minutes) and followed them for a mean of 2.5 years for the primary outcome of ischemic stroke or systemic embolism. Patients with pacemakers were randomly assigned to receive or not to receive continuous atrial overdrive pacing. RESULTS: By 3 months, subclinical atrial tachyarrhythmias detected by implanted devices had occurred in 261 patients (10.1%). Subclinical atrial tachyarrhythmias were associated with an increased risk of clinical atrial fibrillation (hazard ratio, 5.56; 95% confidence interval [CI], 3.78 to 8.17; P<0.001) and of ischemic stroke or systemic embolism (hazard ratio, 2.49; 95% CI, 1.28 to 4.85; P=0.007). Of 51 patients who had a primary outcome event, 11 had had subclinical atrial tachyarrhythmias detected by 3 months, and none had had clinical atrial fibrillation by 3 months. The population attributable risk of stroke or systemic embolism associated with subclinical atrial tachyarrhythmias was 13%. Subclinical atrial tachyarrhythmias remained predictive of the primary outcome after adjustment for predictors of stroke (hazard ratio, 2.50; 95% CI, 1.28 to 4.89; P=0.008). Continuous atrial overdrive pacing did not prevent atrial fibrillation. CONCLUSIONS: Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, occurred frequently in patients with pacemakers and were associated with a significantly increased risk of ischemic stroke or systemic embolism. (Funded by St. Jude Medical; ASSERT ClinicalTrials.gov number, NCT00256152.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retrieved data provide an insight into the natural history and associated sequelae (Healey 2012, Kaplan 2019, Van Gelder 2017, Varma 2005).63,69,74,75”
From 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (2021) · cites this paper as Healey 2012
In the citing paper
“Device-detected, subclinical, atrial, high-rate episodes lasting 6 minutes to 24 hours are associated with increased stroke risk, but the absolute risk is considerably lower than expected based on risk factors alone (Glotzer 2003, Healey 2012, van Gelder 2017).74,75,79”
From 2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society (2021) · cites this paper as Healey 2012
In the citing paper
“AHRE are associated with an increased risk of overt AF (hazard ratio [HR] 5.56; 95% confidence interval [CI] 3.78-8.17;P < 0.001) and ischaemic stroke or systemic embolism (HR 2.49; 95% CI 1.28-4.85;P = 0.007).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“Depending on the risk profile of the population studied, such AHRE are detected in 10-15% of pacemaker patients.141”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“AHRE are associated with an increased risk of overt AF (hazard ratio [HR] 5.56; 95% confidence interval [CI] 3.78-8.17;P < 0.001) and ischaemic stroke or systemic embolism (HR 2.49; 95% CI 1.28-4.85;P = 0.007).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [141]
In the citing paper
“Traditional 24-h monitoring devices (i.e., Holter monitors) often do not detect symptomatic or clinically meaningful arrhythmias [6, 7].”
From Incidence and timing of potentially high-risk arrhythmias detected through long term continuous ambulatory electrocardiographic monitoring (2016) · cites this paper as [6]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750
von Minckwitz, G., du Bois, A., Schmidt, M., Maass, N., Čufer, T., de Jongh, F. E., Maartense, E., Zielinski, C. C., Kaufmann, M., Bauer, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6618 · Cited by 674
Research works printed but not linked: 1
- 10.1001/archinte.147.9.1561 · DOI · Paper page
Cited by
Sorted by citations
Items 901–1,000 of 1,001
What to do with device‐detected atrial high‐rate episodes: Summary of the evidences
Mert, G. Ö., Kepez, A., Mert, K. U., & Görenek, B. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14428 · Cited by 11
Russo, V., Rapacciuolo, A., Rago, A., Tavoletta, V., Vivo, S. D., Ammirati, G., Pergola, V., Ciriello, G. D., Napoli, P., Nigro, G., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12685 · Cited by 12
Jatau, A. I., Bereznicki, L., Wimmer, B. C., Bezabhe, W. M. M., & Peterson, G. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116860 · Cited by 12
“AF can be asymptomatic in about one-third of people with AF [5].”
BackgroundParoxysmal Atrial Fibrillation in Cryptogenic Stroke: an Overlooked Explanation?
Zhang, C., & Kasner, S. E. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0547-0 · Cited by 13
Recent Clinical Trials in Atrial Fibrillation in Hypertensive Patients
Manolis, A. J., Kallistratos, M. S., & Poulimenos, L. E. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0268-5 · Cited by 12
Orrsjö, G., Cederin, B., Bertholds, E., Nasic, S., & Welin, L. (2014) · ISRN Stroke · doi:10.1155/2014/208195 · Cited by 12
Predictors of new onset atrial fibrillation in patients with heart failure
Campbell, N. G. S., Cantor, E. J., Sawhney, V., Duncan, E. R., Demartini, C., Baker, V., Diab, I. G., Dhinoja, M., Earley, M. J., Sporton, S. C., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.05.023 · Cited by 12
Lindsberg, P. J., Toivonen, L. K., & Diener, H. (2014) · BMC Medicine · doi:10.1186/s12916-014-0180-8 · Cited by 12
ANCZYKOWSKI, J., Willems, S., Hoffmann, B. A., Meinertz, T., Blankenberg, S., & Patten, M. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13025 · Cited by 12
Bridge, F., & Thijs, V. (2016) · Journal of Stroke · doi:10.5853/jos.2016.00150 · Cited by 12
Björkenheim, A., Brandes, A., Chemnitz, A., Magnuson, A., Edvardsson, N. G., & Poçi, D. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12916 · Cited by 12
Hayashi, K., Kohno, R., Fujino, Y., Takahashi, M., Oginosawa, Y., Ohe, H., Miyamoto, T., Fukuda, S., Araki, M., Sonoda, S., et al. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0640 · Cited by 11
Filippatos, G. S., Farmakis, D. T., Metra, M., Cotter, G., Davison, B. A., Felker, G. M., Greenberg, B., Hua, T. A., Pang, P. S., Ponikowski, P. P., et al. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1074-x · Cited by 12
Tao, S., Ashikaga, H., Ciuffo, L., Yoneyama, K., Lima, J. A. C., Frank, T. F., Weiss, R. G., Tomaselli, G. F., & Wu, K. C. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13234 · Cited by 12
Long-term monitoring to detect atrial fibrillation with the indwelling implantable cardiac monitors
Sanna, T. (2018) · International Journal of Stroke · doi:10.1177/1747493018790023 · Cited by 12
Malik, V., Ganesan, A. N., Selvanayagam, J. B., Chew, D. P., & McGavigan, A. D. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.08.005 · Cited by 13
Anticoagulation in atrial fibrillation
Barra, S., & Providencia, R. A. (2020) · Heart · doi:10.1136/heartjnl-2020-316728 · Cited by 12
Role of digital health in detection and management of atrial fibrillation
Tooley, J., & Perez, M. V. (2021) · Heart · doi:10.1136/heartjnl-2020-318262 · Cited by 12
Xing, L. Y., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., OLESEN, M. S., Brandes, A., Køber, L., Haugan, K., & Svendsen, J. H. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19333 · Cited by 12
Wang, S.-H., Kang, E. Y., Wang, C., Wen, M., Hung, K., Wang, C., & Chen, T. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu252 · Cited by 12
Engdahl, J., Holmén, A., Rosenqvist, M., & Strömberg, U. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-715 · Cited by 12
High Incidence of Occult Atrial Fibrillation in Asian Patients with Cryptogenic Stroke
Seow, S., How, A. K., Chan, S., Teoh, H. L., Lim, T., Singh, D., Yeo, W., & Kojodjojo, P. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.03.019 · Cited by 12
Performance of an atrial fibrillation detection algorithm using continuous pulse wave monitoring
Kashiwa, A., Koyama, F., Miyamoto, K., Kamakura, T., Wada, M., Yamagata, K., Ishibashi, K., Inoue, Y. Y., Okamura, H., Nagase, S., et al. (2018) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12615 · Cited by 12
Atrial Fibrillation After Cardiac Surgery: Electrophysiological Mechanism and Outcome
Ehrlich, M. P., Osorio‐Jaramillo, E., Aref, T., Coti, I., Andreas, M., Laufer, G., & Ad, N. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.12.069 · Cited by 12
Treatment of Subclinical Atrial Fibrillation
Gold, M. R. (2018) · Circulation · doi:10.1161/circulationaha.117.030096 · Cited by 12
Kalenderoğlu, K., Hayıroğlu, M. İ., Yüksel, G., Bayraktar, G. A., Pay, L., Keskin, K., Coşkun, C., Gürkan, K., & Çınar, T. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03190-6 · Cited by 11
Pisanò, E., Calvi, V. I., Viscusi, M., Rapacciuolo, A., Lazzari, L., Bontempi, L., Pelargonio, G., Arena, G., Caccavo, V., Wang, C.-C., et al. (2024) · EP Europace · doi:10.1093/europace/euae175 · Cited by 14
Peigh, G., Koehler, J. L., Majumder, S., Cho, Y. W., Landman, S. R., Sarkar, S., Ziegler, P., & PASSMAN, R. S. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.06.020 · Cited by 11
Atrial fibrillation burden: Stepping beyond the categorical characterization
Doundoulakis, I., Nedios, S., Zafeiropoulos, S., Vitolo, M., Rocca, D. G. D., Kordalis, A., Shamloo, A. S., Koliastasis, L., Marcon, L., Chiotis, S., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.08.051 · Cited by 12
Antoun, I., Alkhayer, A., Eldin, A. J., Alkhayer, A., Salama, I. A.-K., Yazji, K., Somani, R., Ng, G. A., & Zakkar, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1512558 · Cited by 11
Ahmed, S. R., Zeinhom, M. G., Ebied, A. A. M. K., Kamel, I. F. M., Almoataz, M. A., Daabis, A. M. A., Akl, A. Z. O., Mahmoud, E. L. A., Alkhalefeh, A. G., Ouf, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-97968-3 · Cited by 13
“The (ASSERT) study suggested that as little as six minutes of AF increased stroke risk 32 , while Capucci et al. 33 reported that AF lasting ≥ 24 h led to three times rise in thromboembolic risk and poor outcomes compared to those without AF episodes lasting for 24 h.”
Prevalence of atrial fibrillation and the HATCH score
Tischer, T. S., Schneider, R., Lauschke, J., Diedrich, D., Kundt, G., & Bänsch, D. (2015) · Herz · doi:10.1007/s00059-015-4305-4 · Cited by 11
Alissa, A., Inoue, Y. Y., Cammin, J., Tang, Q., Nazarian, S., Calkins, H. G., Fishman, E. K., Taguchi, K., & Ashikaga, H. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev207 · Cited by 11
Significance and Management Strategies for Patients with Asymptomatic Atrial Fibrillation.
Majos, E., & Dąbrowski, R. (2015) · PubMed Central · doi:10.4022/jafib.1169 · Cited by 11
Biffi, M., Ziacchi, M., Ricci, R. P., Facchin, D., Morani, G., Landolina, M., Lunati, M., Iacopino, S., Capucci, A., Bianchi, S., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.126 · Cited by 11
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.07.001 · Cited by 11
Grubb, N. R., Elder, D. H. J., Broadhurst, P., Reoch, A., Tassie, E., & Neilson, A. R. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.03.062 · Cited by 11
“temporal relationship between high rate episodes and stroke events is not direct [29].”
BackgroundWang, Y., Ma, C., Du, X., He, L., Li, J., Wang, G., Wen, D., Dong, J., Pan, J., & Lip, G. Y. H. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1260-7 · Cited by 11
Pecha, S., Wilke, I., Yıldırım, Y., Reichenspurner, H. C., & Aydin, M. A. (2020) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2020.04.007 · Cited by 11
Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11
“1% of patients and were associated with an increased risk of ischemic stroke or systemic embolism.(11) In the non-HCM population, an SCAF duration of > 6 minutes increases the risk of stroke 2.”
BackgroundResultYarza, S., Novack, L., Sarov, B., & Novack, V. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114804 · Cited by 11
The Complex Genetics of Atrial Fibrillation
Judge, D. P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.031 · Cited by 12
Olsen, F. J., Biering‐Sørensen, T., & Krieger, D. W. (2015) · Future Cardiology · doi:10.2217/fca.15.15 · Cited by 11
Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
Brimble, K. S., Ingram, A. J., Eikelboom, J. W., & Hart, R. G. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.11.2609 · Cited by 11
Documentation of atrial fibrillation prior to first-ever ischemic stroke
Baturova, M. A., Lindgren, A. G., Shubik, Y. V., Olsson, S., & Platonov, P. G. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12203 · Cited by 11
Can air pollution trigger an onset of atrial fibrillation: a population-based study
Yitshak‐Sade, M., Vodonos, A., Novack, V., Friger, M. D., Amit, G., Katra, I., Schwartz, J. D., & Novack, L. (2014) · Air Quality Atmosphere & Health · doi:10.1007/s11869-014-0295-2 · Cited by 11
Solari, D., Bertero, E., Miceli, R., Brunelli, C., Ameri, P., & Canepa, M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.189 · Cited by 11
Domínguez, H., Madsen, C. V., Westh, O. N. H., Pallesen, P. A., Carranza, C. L., Irmukhamedov, A., & Park-Hansen, J. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1033-4 · Cited by 11
Sandgren, E., Rorsman, C., Edvardsson, N. G., & Engdahl, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203661 · Cited by 12
The incidence of atrial fibrillation and the added value of thumb ECG for detecting new cases
Mandalenakis, Z., Lennartsson, S. T., Fu, M. L. X., Lappas, G., Li, S., Rosengren, A., Dellborg, M., Thunström, E. Ö., Caidahl, K., & Hansson, P. (2018) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2018.1509120 · Cited by 11
Stroke prevention in atrial fibrillation: Closing the gap
Pokorney, S. D., Gersh, B. J., Ahmad, A., Al‐Khatib, S. M., Blank, M. J., Coylewright, M. J., DiBattiste, P. M., Healey, J. S., Hedrich, O., Hylek, E. M., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.10.004 · Cited by 11
“month period) was identified on an implanted cardiac device.(68) Subsequent analyses from ASSERT have shown that there was no statistically significant association between AF lasting 6 minutes to 24 hours and stroke, whereas there was an association between subclinical AF lasting N24 hours and stroke (adjusted HR 3.”
MethodUsefulness of P Wave Duration in Embolic Stroke of Undetermined Source
Jung, M., Kim, J. S., Song, J. H., Kim, J., Park, K., Lee, W. S., Kim, S., Lip, G. Y. H., & Shin, S. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041134 · Cited by 14
Assessing Atrial Fibrillation Substrates by P Wave Analysis: A Comprehensive Review
Palano, F., Adduci, C., Cosentino, P., Silvetti, G., Boldini, F., & Francia, P. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00390-1 · Cited by 11
Arai, S., Kawamura, M., Gokan, T., Yoshikawa, K., Ogawa, K., Ochi, A., Munetsugu, Y., Ito, H., & Shinke, T. (2020) · Clinical Cardiology · doi:10.1002/clc.23471 · Cited by 11
Zakeri, R., Morgan, J. M., Phillips, P., Kitt, S., Ng, G. A., McComb, J. M., Williams, S. G., Wright, D. J., Gill, J. S., Seed, A., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.008 · Cited by 11
Khurshid, S. S., Chen, W., Singer, D. E., Atlas, S. J., Ashburner, J. M., Choi, J., Hur, C., Ellinor, P. T., McManus, D. D., Chhatwal, J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020330 · Cited by 12
Hoshi, Y., Nozawa, Y., Ogasawara, M., Yuda, S., Sato, A., Sakasai, T., Oka, M., Katayama, H., Sato, M., Kouzu, H., et al. (2013) · Echocardiography · doi:10.1111/echo.12329 · Cited by 11
Cryptogenic Stroke And Role Of Loop Recorder.
Pérez‐Rodon, J., Pascual, J. F., Rivas‐Gándara, N., Roca‐Luque, I., Bellera, N., & Moya‐Mitjans, À. (2014) · PubMed Central · doi:10.4022/jafib.1178 · Cited by 11
Banerjee, S., Majumdar, S., & Konar, A. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12239 · Cited by 11
Ueda, N., Kamakura, T., Noda, T., Nakajima, K., Kataoka, N., Wada, M., Yamagata, K., Ishibashi, K., Inoue, Y. Y., Miyamoto, K., et al. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.10.001 · Cited by 11
Healey, J. S., Lópes, R. D., & Connolly, S. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv159 · Cited by 11
Interatrial Block to Guide the Thromboembolic Prevention Strategy: Should It be the Next Step?
Chhabra, L., & Gowdar, S. D. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.05.029 · Cited by 11
Measuring Success in Ablation of Atrial Fibrillation
Terricabras, M., Verma, A., & Morillo, C. A. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006582 · Cited by 11
Does asymptomatic atrial fibrillation exist?
Carneiro, H. A., & Knight, B. P. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16108 · Cited by 11
Boriani, G., McIntyre, W. F., Ramasundarahettige, C. F., Proietti, M., Glotzer, T. V., Diemberger, I., Nielsen, J. C., Essebag, V., Granger, C. B., Sandhu, R. K., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.07.002 · Cited by 10
Misconceptions and Facts About Atrial Fibrillation
Argulian, E., Conen, D., & Messerli, F. H. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.02.016 · Cited by 10
A Critical Perspective on the Role of Catheter Ablation in Management of Atrial Fibrillation
Wyse, D. G. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.001 · Cited by 10
Atrial fibrillation post central retinal artery occlusion: Role of implantable loop recorders
Watson, R. A., Wellings, J., Hingorani, R., Zhan, T., Frisch, D. R., Ho, R. T., Pavri, B. B., Sergott, R. C., & Greenspon, A. J. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13990 · Cited by 10
Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial Fibrillation
Elkind, M. S. V., Wachter, R., Verma, A., Kowey, P. R., Halperin, J. L., Gersh, B. J., Ziegler, P., Pouliot, E., Franco, N. C., & Reiffel, J. A. (2021) · Cardiology · doi:10.1159/000517827 · Cited by 10
Liu, X., Guo, S., & Xu, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.961000 · Cited by 10
“The main findings of our meta-analysis on the effectiveness and safety outcomes of OAC versus no OAC in patients with AF after ICH are summarized as follows: (1) OAC was correlated with a lower risk of stroke or systemic embolism, ischemic stroke, and all-cause death but a similar risk of major bleeding and major recu…”
BackgroundResultInfluentialFernandez, V., Béjot, Y., Zeller, M., Hamblin, J., Daubail, B., Jacquin, A., Maza, M., Touzery, C., Cottin, Y., & Giroud, M. (2014) · European Neurology · doi:10.1159/000357561 · Cited by 10
Bojarnejad, M., Blake, Bourke, J. P., Shepherd, E., Murray, A., & Langley, P. (2014) · Europe PMC (PubMed Central) · doi:10.25405/ncl.34303719 · Cited by 10
Monitoring for AF: Identifying the Burden of Atrial Fibrillation and Assessing Post-Ablation
PASSMAN, R. S. (2017) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2017.080104 · Cited by 10
Miyazawa, K., Kondo, Y., Nakano, M., Esteve‐Pastor, M. A., Rivera‐Caravaca, J. M., Senoo, K., Kobayashi, Y., & Lip, G. Y. H. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.019 · Cited by 10
Antiplatelet agents in uncertain clinical scenarios—a bleeding nightmare
Esmonde, S., Sharma, D., & Peace, A. J. (2018) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.06.09 · Cited by 10
“A recent systematic review, of over half a million participants post-PCI, found that major bleeding increased Table 2 Clinical risk factors associated with increased ischemic and bleeding risk (38-44)”
BackgroundWytyczne ESC dotyczące stymulacji serca i terapii resynchronizującej w 2013 roku
Suplement, K. P. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0182 · Cited by 10
Parental Atrial Fibrillation and Stroke or Atrial Fibrillation in Young Adults
McAlister, F. A., Yan, L., Roos, L. L., & Lix, L. M. (2019) · Stroke · doi:10.1161/strokeaha.119.025124 · Cited by 11
“These AF codes in hospital discharge records have a specificity of >99% for identification of AF.9–11 We did not use ambulatory billing records in the algorithm to define parental AF because this would have increased the number of false positive diagnoses substantially: whereas hospital discharge records include digit…”
BackgroundInfluentialXu, J., Sethi, P. P., Biby, S., Allred, J. D., Seiler, A. K., & Sabir, R. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.104934 · Cited by 10
Okubo, Y., Tokuyama, T., Okamura, S., Ikeuchi, Y., Miyauchi, S., Nakano, Y., & for the MYBEAT Trial Investigators (2021) · Circulation Journal · doi:10.1253/circj.cj-20-1061 · Cited by 10
Cor triatriatum sinister and cryptogenic stroke
Ridjab, D. A., Wittchen, F., Tschishow, W. N., Buddecke, J., Lamp, B., Manegold, J. C., Schäbitz, W., & Israel, C. W. (2013) · Herz · doi:10.1007/s00059-013-3934-8 · Cited by 10
Left Atrial Appendage Morphology and Physiology: “The Missing Piece in the Puzzle”
Romero, J. E., Natale, A., & Biase, L. D. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12746 · Cited by 10
Frontera, A., Carpenter, A., Ahmed, N., Fasiolo, M., Nelson, M. A., Diab, I. G., Cripps, T., Thomas, G., & Duncan, E. R. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12692 · Cited by 10
Management of Device-detected Atrial High-rate Episodes
Tomson, T. T., & PASSMAN, R. S. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.010 · Cited by 10
Embolic Stroke of Undetermined Source in Latin America
Cantú-Brito, C. G., Silva, G. S., & Ameriso, S. F. (2017) · The Neurologist · doi:10.1097/nrl.0000000000000128 · Cited by 10
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
Ioannou, A., Tsappa, I., Metaxa, S., & Missouris, C. G. (2017) · Patient Related Outcome Measures · doi:10.2147/prom.s117549 · Cited by 10
Conti, S., Reiffel, J. A., Gersh, B. J., Kowey, P. R., Wachter, R., Halperin, J. L., Kaplon, R. E., Pouliot, E., & Verma, A. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1551 · Cited by 10
Pascual, J. F., Olivella, A., Rivas‐Gándara, N., Pérez‐Rodon, J., Benito, B., Santos‐Ortega, A., Moya‐Mitjans, À., Rodríguez‐García, J., Butron, S. I. L., Romero, J. C., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.05.078 · Cited by 10
Sakhi, R., Huurman, R., Theuns, D. A. M. J., Schinkel, A. F. L., Assaf, A., Szili‐Törok, T., Roos‐Hesselink, J. W., Michels, M., & Yap, S. (2021) · Cardiology · doi:10.1159/000512656 · Cited by 10
Atrial Fibrillation in Cryptogenic Stroke
Lau, Y. C., Lane, D. A., & Lip, G. Y. H. (2014) · Stroke · doi:10.1161/strokeaha.114.006862 · Cited by 10
Seek and Ye Shall Find Fibrillations
Rose, D. Z., Falcão, D., & Martin, R. C. (2016) · Stroke · doi:10.1161/strokeaha.116.013987 · Cited by 10
Hohnloser, S. H., & Vámos, M. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004847 · Cited by 10
Halimi, F., Sabouret, P. F., Huberman, J.-P., Ouazana, L., Guedj, D., Djouadi, K., Dhanjal, T., Goette, A., Lafont, C., & Lellouche, N. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02109-9 · Cited by 9
Kwun, J.-S., Lee, J. H., Park, B. E., Park, J. S., Kim, H. J., Kim, S., Jeon, K., Cho, H.-W., Kang, S., Lee, W., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/45760 · Cited by 9
“Despite early detection and accurate diagnosis of arrhythmias being crucial for preventing adverse outcomes [5], atrial fibrillation is often both asymptomatic and intermittent, making it difficult to capture these episodic events [6,7].”
Jiang, J., Mi, L., Chen, K., Hua, W., Su, Y., Xu, W., Zhao, S., & Zhang, S. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.12.007 · Cited by 9
Diretriz sobre Diagnóstico e Tratamento da Cardiomiopatia Hipertrófica – 2024
Fernandes, F., Simões, M. V., Correia, E. D. B., Marcondes‐Braga, F. G., Coelho‐Filho, O. R., Mesquita, C. T., Mathias, W., Antunes, M. D. O., Arteaga-Fernández, E., Rochitte, C. E., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240415 · Cited by 31
Fleury, Q., Dubois, R., Christophle-Boulard, S., Extramiana, F., & Maison‐Blanche, P. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.09.007 · Cited by 9
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation
Heine, G. H., Schneppe, C., Bauersachs, R. M., Eitel, I., Neuen, B. L., Ruff, C. T., Schirmer, S. H., & Vriese, A. S. D. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae270 · Cited by 12
“…Reduction atrial pacing Trial) study demonstrated higher rates of clinical overt AF as well as strokes in patients with subclinical AF, defined as atrial high rate episodes ( AHRE) only detected by implanted devices ( mostly pacemakers and implantable cardioverter defibrillators) [11 ].”
BackgroundSubclinical atrial fibrillation: how hard should we look?
Wachter, R., Stahrenberg, R., & Gröschel, K. (2012) · Heart · doi:10.1136/heartjnl-2012-302248 · Cited by 9
Fibrillation atriale infraclinique
Lenormand, T., Bisson, A., & Fauchier, L. (2024) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2024.09.002
Engdahl, J., Andersson, L., Mirskaya, M., & Rosenqvist, M. (2013) · Circulation · doi:10.1161/circulationaha.112.126656 · Cited by 233
Metadata
- Authors
- Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., Morillo, C. A., Carlson, M., Themeles, E., Kaufman, E. S., & Hohnloser, S. H.
- Affiliations
- Population Health Research Institute (CA)
- Medical University of South Carolina (US)
- Goethe University Frankfurt (DE)
- Marche Polytechnic University (IT)
- Queen Mary Hospital (CN)
- MetroHealth (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-01-12
- Volume
- 366
- Issue
- 2
- Pages
- 120-129
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154658516
- Cited by
- 2,100
- References
- 37
- Citations by year
- 2026: 87 · 2025: 104 · 2024: 137 · 2023: 116 · 2022: 134 · 2021: 153 · 2020: 148 · 2019: 162 · 2018: 154 · 2017: 154 · 2016: 162 · 2015: 146 · 2014: 181 · 2013: 133 · 2012: 124
- FWCI
- 120.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- subclinical atrial fibrillation, atrial tachyarrhythmia, ischemic stroke, systemic embolism, atrial overdrive pacing, atrial fibrillation risk, hypertension, elderly patients, population attributable risk, stroke prevention, cardiac implantable electronic devices, atrial fibrillation detection, atrial fibrillation prevention
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Cardiac Pacing, Artificial, Embolism, Female, Humans, Hypertension, Male, Pacemaker, Artificial, Prospective Studies, Risk, Defibrillators, Implantable, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review